CEO Lori Koch attributed the performance to disciplined execution of strategic priorities and robust demand across key markets. The company saw mid-single-digit organic growth in its Healthcare & Water Technologies segment, bolstered by strength in biopharma and personal protection, while the Diversified Industrials segment benefited from ongoing demand in aerospace and electric vehicle applications.
DuPont Raises Full-Year Outlook After Strong Second Quarter
DuPont reported second-quarter 2026 results that surpassed internal guidance, with net sales reaching $1.8 billion, a 4% increase over the previous year. Driven by organic growth and improved productivity, the Wilmington-based company raised its full-year financial projections and announced plans for a $250 million share repurchase program.
Following the second-quarter outperformance, CFO Antonella Franzen increased the midpoint of the company's full-year 2026 operating EBITDA guidance to approximately $1.76 billion. Adjusted earnings per share are now expected to reach $7.24, with organic sales growth projected to climb slightly above 4%. The company also finalized its transition to the Industrials GICS classification effective July 31, 2026, marking a continued shift in its operational focus.
Comments (0)
No comments yet. Be the first!